Medline, Inc. (MDLN)
32.38
-1.30
(-3.87%)
USD |
NASDAQ |
Oct 27, 16:00
32.49
+0.10
(+0.32%)
After-Hours: 20:00
Medline Market Cap : 28.40B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 29.55B |
| October 23, 2026 | 29.90B |
| October 22, 2026 | 30.59B |
| October 21, 2026 | 30.97B |
| October 20, 2026 | 31.10B |
| October 19, 2026 | 30.86B |
| October 16, 2026 | 31.54B |
| October 15, 2026 | 32.07B |
| October 14, 2026 | 31.51B |
| October 13, 2026 | 31.31B |
| October 12, 2026 | 31.36B |
| October 09, 2026 | 31.80B |
| October 08, 2026 | 31.34B |
| October 07, 2026 | 31.09B |
| October 06, 2026 | 31.18B |
| October 05, 2026 | 31.40B |
| October 02, 2026 | 31.23B |
| October 01, 2026 | 30.64B |
| September 30, 2026 | 30.43B |
| September 29, 2026 | 30.68B |
| September 28, 2026 | 30.76B |
| September 25, 2026 | 30.43B |
| September 24, 2026 | 30.40B |
| September 23, 2026 | 30.08B |
| September 22, 2026 | 30.20B |
| Date | Value |
|---|---|
| September 21, 2026 | 28.03B |
| September 18, 2026 | 27.75B |
| September 17, 2026 | 28.17B |
| September 16, 2026 | 28.93B |
| September 15, 2026 | 28.16B |
| September 14, 2026 | 28.58B |
| September 11, 2026 | 28.53B |
| September 10, 2026 | 28.41B |
| September 09, 2026 | 29.86B |
| September 08, 2026 | 30.42B |
| September 04, 2026 | 32.09B |
| September 03, 2026 | 32.09B |
| September 02, 2026 | 31.84B |
| September 01, 2026 | 30.79B |
| August 31, 2026 | 30.72B |
| August 28, 2026 | 30.94B |
| August 27, 2026 | 30.39B |
| August 26, 2026 | 30.33B |
| August 25, 2026 | 31.26B |
| August 24, 2026 | 30.43B |
| August 21, 2026 | 30.05B |
| August 20, 2026 | 28.57B |
| August 19, 2026 | 29.74B |
| August 18, 2026 | 29.92B |
| August 17, 2026 | 30.59B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insulet Corp. | 10.39B |
| Abbott Laboratories | 178.45B |
| AngioDynamics, Inc. | 520.12M |
| Alphatec Holdings, Inc. | 1.657B |
| AtriCure, Inc. | 3.130B |
Market Cap Related Metrics
| PE Ratio | 37.97 |
| PS Ratio | 0.8918 |
| Price to Book Value | 2.454 |
| Price to Free Cash Flow | 17.27 |
| Price | 32.38 |
| Earnings Yield | 2.63% |
| Operating PE Ratio | 13.71 |
| Normalized PE Ratio | 24.08 |